Chronic Kidney Disease Drugs Market
Chronic Kidney Disease Drugs Market, In a survey released on April 23, 2020 by Medidata Solutions, Inc., an American technology company that creates and sells software as a service for clinical trials, 63% of respondents said they had stopped taking on new participants for ongoing clinical trials, and 43% said they had delayed their studies globally. Guidelines for conducting clinical trials of medical products during the COVID-19 public health emergency were released by the U.S. Food and Drug Administration (FDA) in March 2020. On July 2, 2020, the rules were updated once more.
Read More:
https://knackersblogger.blogspot.com/2023/02/chronic-kidney-disease-drugs-market.html
